Quanterix Corp Asset Resilience Ratio
Quanterix Corp asset resilience ratio. Quanterix Corp (QTRX) has an Asset Resilience Ratio of 15.44% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Quanterix Corp liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Quanterix Corp (2022–2025)
Asset resilience ratio of Quanterix Corp from 2022 to 2025. This chart shows how Quanterix Corp's Asset Resilience Ratio has changed over time. Read Quanterix Corp total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Quanterix Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Quanterix Corp total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $49.36 Million | 15.44% |
| Total Liquid Assets | $49.36 Million | 15.44% |
Asset Resilience Insights
- Good Liquidity Position: Quanterix Corp maintains a healthy 15.44% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Quanterix Corp Industry Peers by Asset Resilience Ratio
Compare Quanterix Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Quanterix Corp Asset Resilience Ratio by Year (2022–2025)
Quanterix Corp asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Quanterix Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 21.11% | $88.39 Million | $418.77 Million | -36.06pp |
| 2024-12-31 | 57.17% | $232.41 Million | $406.53 Million | +22.89pp |
| 2023-12-31 | 34.28% | $146.90 Million | $428.57 Million | -- |
| 2022-12-31 | 0.00% | $0.00 | $433.58 Million | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measureme… Read more